580 |
Marathi |
HIV in TB Patients |
Final Review |
|
Awele |
Abhimanyu |
4 months 3 weeks |
580 |
Telugu |
HIV in TB Patients |
Approved |
|
Awele |
Abhimanyu |
4 months 3 weeks |
704 |
English |
DR-TB Centres and Network |
Final Review |
Link |
Awele |
Abhimanyu |
4 months 3 weeks |
704 |
Marathi |
DR-TB Centres and Network |
Approved |
|
Awele |
Abhimanyu |
4 months 3 weeks |
704 |
Telugu |
DR-TB Centres and Network |
Approved |
|
Awele |
Abhimanyu |
4 months 3 weeks |
723 |
English |
Classification of TB on the basis of Site of disease |
Approved |
Link |
Archana.Singh |
Abhimanyu |
4 months 3 weeks |
723 |
Marathi |
Classification of TB on the basis of Site of disease |
Approved |
|
Archana.Singh |
Abhimanyu |
4 months 3 weeks |
723 |
Telugu |
Classification of TB on the basis of Site of disease |
Approved |
|
Archana.Singh |
Abhimanyu |
4 months 3 weeks |
732 |
English |
Integrated DR-TB Algorithm |
Approved |
Link |
Archana.Singh |
Abhimanyu |
4 months 3 weeks |
804 |
English |
Recording Adherence in Treatment card |
Published on LMS |
Link |
Awele |
Abhimanyu |
4 months 3 weeks |
804 |
Marathi |
Recording Adherence in Treatment card |
Published on LMS |
|
Awele |
Abhimanyu |
4 months 3 weeks |
804 |
Telugu |
Recording Adherence in Treatment card |
Published on LMS |
|
Awele |
Abhimanyu |
4 months 3 weeks |
805 |
English |
Recording Adherence using TB Arogya Sathi Application |
Published on LMS |
Link |
Awele |
Abhimanyu |
4 months 3 weeks |
805 |
Marathi |
Recording Adherence using TB Arogya Sathi Application |
Published on LMS |
|
Awele |
Abhimanyu |
4 months 3 weeks |
805 |
Telugu |
Recording Adherence using TB Arogya Sathi Application |
Published on LMS |
|
Awele |
Abhimanyu |
4 months 3 weeks |
877 |
English |
Monitoring of Adherence by NTEP Staff |
Published on LMS |
Link |
RichardS |
Abhimanyu |
4 months 3 weeks |
877 |
Marathi |
Monitoring of Adherence by NTEP Staff |
Published on LMS |
|
RichardS |
Abhimanyu |
4 months 3 weeks |
877 |
Telugu |
Monitoring of Adherence by NTEP Staff |
Published on LMS |
|
RichardS |
Abhimanyu |
4 months 3 weeks |
884 |
English |
Supportive Supervision |
Approved |
Link |
Abhimanyu |
RakeshPS |
4 months 3 weeks |
884 |
Marathi |
Supportive Supervision |
Approved |
|
Abhimanyu |
RakeshPS |
4 months 3 weeks |
884 |
Telugu |
Supportive Supervision |
Approved |
|
Abhimanyu |
RakeshPS |
4 months 3 weeks |
900 |
English |
Beneficiary Registration |
Published on LMS |
Link |
Awele |
Abhimanyu |
4 months 3 weeks |
900 |
Marathi |
Beneficiary Registration |
|
|
Awele |
Abhimanyu |
4 months 3 weeks |
900 |
Telugu |
Beneficiary Registration |
|
|
Awele |
Abhimanyu |
4 months 3 weeks |
901 |
English |
Benefits Processing in Nikshay |
Published on LMS |
Link |
AmalS |
PrashantBhat |
4 months 3 weeks |
901 |
Marathi |
Benefits Processing in Nikshay |
Published on LMS |
|
AmalS |
PrashantBhat |
4 months 3 weeks |
901 |
Telugu |
Benefits Processing in Nikshay |
Published on LMS |
|
AmalS |
PrashantBhat |
4 months 3 weeks |
939 |
English |
Incentive For Notification and Outcome Declaration |
Published on LMS |
Link |
RichardS |
Abhimanyu |
4 months 3 weeks |
939 |
Marathi |
Incentive For Notification and Outcome Declaration |
Published on LMS |
|
RichardS |
Abhimanyu |
4 months 3 weeks |
939 |
Telugu |
Incentive For Notification and Outcome Declaration |
Published on LMS |
|
RichardS |
Abhimanyu |
4 months 3 weeks |
902 |
English |
Action by DBT Maker/Checker in Nikshay interface |
Under Development |
Link |
Awele |
Abhimanyu |
4 months 3 weeks |
902 |
Marathi |
Action by DBT Maker/Checker in Nikshay interface |
Published on LMS |
|
Awele |
Abhimanyu |
4 months 3 weeks |
902 |
Telugu |
Action by DBT Maker/Checker in Nikshay interface |
Under Development |
|
Awele |
Abhimanyu |
4 months 3 weeks |
1003 |
English |
Management of DR-TB ADR: Hematological Abnormalities |
Page Prioritised |
Link |
Archana.Singh |
Abhimanyu |
4 months 3 weeks |
1004 |
English |
Management of DR-TB ADR: Hypothyroidism |
Page Prioritised |
Link |
Archana.Singh |
Abhimanyu |
4 months 3 weeks |
1005 |
English |
Management of DR-TB ADR: Arthralgia |
Page Prioritised |
Link |
Awele |
Abhimanyu |
4 months 3 weeks |
1007 |
English |
Management of DR-TB ADR: Psychotic Symptoms |
Final Review |
Link |
Dr. Priyadarshini |
Abhimanyu |
4 months 3 weeks |
1010 |
English |
Management of DR-TB ADR: Nephrotoxicity [Renal Toxicity] |
Page Prioritised |
Link |
Dr. Priyadarshini |
Abhimanyu |
4 months 3 weeks |
1011 |
English |
Management of DR-TB ADR: Gynecomastia |
Final Review |
Link |
NimishaArora |
Abhimanyu |
4 months 3 weeks |
1032 |
English |
Delamanid [Dlm] Drug Dosages and Duration |
Page Prioritised |
Link |
NimishaArora |
Abhimanyu |
4 months 3 weeks |
1075 |
English |
Drug-resistant TB Service Linkages to Private Sectors |
Page Prioritised |
Link |
Awele |
Abhimanyu |
4 months 3 weeks |
1122 |
English |
Follow-up Monitoring for individuals taking TPT |
Approved |
Link |
Dr. Priyadarshini |
Abhimanyu |
4 months 3 weeks |
1126 |
English |
Newer Anti-TB Drugs: Bedaquiline [Bdq] |
Final Review |
Link |
NimishaArora |
Abhimanyu |
4 months 3 weeks |
1128 |
English |
Newer Anti-TB Drugs: Delamanid [Dlm] |
Page Prioritised |
Link |
Archana.Singh |
Abhimanyu |
4 months 3 weeks |
1129 |
English |
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Pre-treatment Evaluation [PTE] |
Approved |
Link |
Archana.Singh |
Abhimanyu |
4 months 3 weeks |
1130 |
English |
Causes for Drug-resistant Tuberculosis |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
4 months 3 weeks |
1132 |
English |
Baseline Second-line Drug-susceptibility Testing |
Page Prioritised |
Link |
NimishaArora |
Abhimanyu |
4 months 3 weeks |
1133 |
English |
Prevention of Drug-resistance |
Final Review |
Link |
NimishaArora |
Abhimanyu |
4 months 3 weeks |
1136 |
English |
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Eligibility Criteria |
Approved |
Link |
Archana.Singh |
Abhimanyu |
4 months 3 weeks |
1137 |
English |
Requirements from Institutions for the Establishment of Nodal DR-TB Centre |
Final Review |
Link |
NimishaArora |
Abhimanyu |
4 months 3 weeks |